HIV-Associated Tuberculosis in Adults: Diagnosis and Clinical Management
) and is currently not widely available. Management of rifampicin-resistant TB now involves a 6month all-oral regimen for most patients, including PWH. While significant gains have recently been made toward decreasing mortality from HIV-associated TB, there are many ongoing challenges, some of which are being addressed in active clinical trials.
Authors
- Bianca Sossen (ORCID: https://orcid.org/0000-0002-6028-3351)
- Graeme Meintjes
Institutions
- University of Cape Town (ZA)
- Queen Mary University of London (GB)
- Wellcome Centre for Infectious Diseases Research in Africa (ZA)
Publication Details
- Journal
- Cold Spring Harbor Perspectives in Medicine
- Published
- 2026-05-18
- DOI
- https://doi.org/10.1101/cshperspect.a041889
- Primary Topic
- Infectious Diseases and Tuberculosis
- Type
- preprint